$SENS
Senseonics Holdings, Inc.

2020 Q2 Form 10-Q Financial Statement

#000155837020010163 Filed on August 10, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2 2019 Q1
Revenue $261.0K $4.607M $3.423M
YoY Change -94.33% 27.27% 16.03%
Cost Of Revenue $1.404M $9.160M $6.733M
YoY Change -84.67% 138.54% 103.41%
Gross Profit -$1.143M -$4.553M -$3.310M
YoY Change -74.9% 1969.55% 819.44%
Gross Profit Margin -437.93% -98.83% -96.7%
Selling, General & Admin $7.587M $19.60M $19.35M
YoY Change -61.28% 69.52% 159.73%
% of Gross Profit
Research & Development $3.796M $10.50M $7.108M
YoY Change -63.86% 26.71% -12.36%
% of Gross Profit
Depreciation & Amortization $281.0K $218.0K $200.0K
YoY Change 28.9% 336.0% 300.0%
% of Gross Profit
Operating Expenses $11.38M $30.10M $26.46M
YoY Change -62.18% 51.64% 70.04%
Operating Profit -$12.53M -$34.65M -$29.77M
YoY Change -63.85% 72.66% 86.98%
Interest Expense $3.555M $3.334M $665.0K
YoY Change 6.63% -127.42% -141.82%
% of Operating Profit
Other Income/Expense, Net $5.011M $3.579M -$262.0K
YoY Change 40.01% -1425.56% -94.5%
Pretax Income -$7.515M -$31.07M -$29.37M
YoY Change -75.82% -4.39% 31.86%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$7.515M -$31.07M -$29.37M
YoY Change -75.82% -4.39% 31.86%
Net Earnings / Revenue -2879.31% -674.5% -857.87%
Basic Earnings Per Share
Diluted Earnings Per Share -$34.11K -$175.5K -$165.9K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q2 2019 Q2 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $21.40M $65.30M $103.7M
YoY Change -67.23% -65.97% 59.25%
Cash & Equivalents $21.40M $65.30M $103.7M
Short-Term Investments
Other Short-Term Assets $5.888M $6.091M $4.698M
YoY Change -3.33% 45.02% 38.18%
Inventory $4.150M $16.79M $14.37M
Prepaid Expenses
Receivables $670.0K $5.802M $2.367M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $32.11M $93.98M $125.1M
YoY Change -65.84% -54.71% 62.9%
LONG-TERM ASSETS
Property, Plant & Equipment $1.771M $4.303M $4.177M
YoY Change -58.84% 330.3% 422.12%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $4.245M
YoY Change
Other Assets $2.716M $117.0K $114.0K
YoY Change 2221.37% -41.5% -43.0%
Total Long-Term Assets $8.732M $4.420M $4.291M
YoY Change 97.56% 268.33% 329.1%
TOTAL ASSETS
Total Short-Term Assets $32.11M $93.98M $125.1M
Total Long-Term Assets $8.732M $4.420M $4.291M
Total Assets $40.84M $98.40M $129.4M
YoY Change -58.5% -52.85% 66.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $106.0K $4.779M $3.274M
YoY Change -97.78% -8.1% -33.18%
Accrued Expenses $12.13M $18.65M $13.82M
YoY Change -34.97% 116.81% 122.89%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $9.901M $10.00M
YoY Change -100.0% -0.99% 0.0%
Total Short-Term Liabilities $12.28M $33.60M $27.46M
YoY Change -63.46% 34.42% 27.72%
LONG-TERM LIABILITIES
Long-Term Debt $61.19M $37.82M $39.30M
YoY Change 61.82% -14.25% -14.57%
Other Long-Term Liabilities $1.895M $11.80M $18.70M
YoY Change -83.95% -65.08% -20.42%
Total Long-Term Liabilities $1.895M $49.62M $58.00M
YoY Change -96.18% -36.3% -16.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.28M $33.60M $27.46M
Total Long-Term Liabilities $1.895M $49.62M $58.00M
Total Liabilities $80.44M $83.22M $85.46M
YoY Change -3.34% -19.2% -6.09%
SHAREHOLDERS EQUITY
Retained Earnings -$523.5M
YoY Change
Common Stock $231.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$39.61M $15.17M $43.94M
YoY Change
Total Liabilities & Shareholders Equity $40.84M $98.40M $129.4M
YoY Change -58.5% -52.85% 66.33%

Cashflow Statement

Concept 2020 Q2 2019 Q2 2019 Q1
OPERATING ACTIVITIES
Net Income -$7.515M -$31.07M -$29.37M
YoY Change -75.82% -4.39% 31.86%
Depreciation, Depletion And Amortization $281.0K $218.0K $200.0K
YoY Change 28.9% 336.0% 300.0%
Cash From Operating Activities -$16.73M -$35.70M -$30.15M
YoY Change -53.14% 79.68% 47.08%
INVESTING ACTIVITIES
Capital Expenditures -$78.00K -$344.0K -$392.0K
YoY Change -77.33% 102.35% 3820.0%
Acquisitions
YoY Change
Other Investing Activities $98.00K -$98.00K
YoY Change -102.59% -100.6%
Cash From Investing Activities -$78.00K -$246.0K -$490.0K
YoY Change -68.29% -93.77% -103.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 19.60M -2.430M -2.476M
YoY Change -906.54% -101.65% -105.05%
NET CHANGE
Cash From Operating Activities -16.73M -35.70M -30.15M
Cash From Investing Activities -78.00K -246.0K -490.0K
Cash From Financing Activities 19.60M -2.430M -2.476M
Net Change In Cash 2.792M -38.38M -33.12M
YoY Change -107.27% -131.19% -174.01%
FREE CASH FLOW
Cash From Operating Activities -$16.73M -$35.70M -$30.15M
Capital Expenditures -$78.00K -$344.0K -$392.0K
Free Cash Flow -$16.65M -$35.36M -$29.76M
YoY Change -52.91% 79.49% 45.24%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
230551676
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
203452812
dei Entity Registrant Name
EntityRegistrantName
SENSEONICS HOLDINGS, INC.
dei Entity Central Index Key
EntityCentralIndexKey
0001616543
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37717
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-1210911
dei Entity Address Address Line1
EntityAddressAddressLine1
20451 Seneca Meadows Parkway
dei Entity Address City Or Town
EntityAddressCityOrTown
Germantown
dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20876-7005
dei City Area Code
CityAreaCode
301
dei Local Phone Number
LocalPhoneNumber
515-7260
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
dei Trading Symbol
TradingSymbol
SENS
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
231557506
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21397000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
95938000
CY2020Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
200000
CY2020Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
670000
CY2019Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
3239000
CY2019Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
7140000
CY2020Q2 us-gaap Inventory Net
InventoryNet
4150000
CY2019Q4 us-gaap Inventory Net
InventoryNet
16929000
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5688000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4512000
CY2020Q2 us-gaap Assets Current
AssetsCurrent
32105000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
127758000
CY2020Q2 us-gaap Derivative Assets Noncurrent
DerivativeAssetsNoncurrent
4245000
CY2020Q2 sens Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
2716000
CY2019Q4 sens Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
3042000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1771000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2001000
CY2020Q2 us-gaap Assets
Assets
40837000
CY2019Q4 us-gaap Assets
Assets
132801000
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
106000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4285000
CY2020Q2 sens Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
12174000
CY2019Q4 sens Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
18636000
CY2019Q4 us-gaap Notes Payable To Bank Current
NotesPayableToBankCurrent
43434000
CY2019Q4 us-gaap Convertible Subordinated Debt Current
ConvertibleSubordinatedDebtCurrent
60353000
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
12280000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
126708000
CY2020Q2 us-gaap Long Term Debt
LongTermDebt
61192000
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
11800000
CY2020Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
5075000
CY2019Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
664000
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1895000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2278000
CY2020Q2 us-gaap Liabilities
Liabilities
80442000
CY2019Q4 us-gaap Liabilities
Liabilities
141450000
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
230551676
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
203452812
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
231000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
203000
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
483615000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
464491000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-523451000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-473343000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-39605000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-8649000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
40837000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
132801000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
216000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1475000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
247000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2718000
CY2020Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
45000
CY2019Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
3132000
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
50000
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10504000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11159000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17612000
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4445000
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
5312000
CY2020Q2 us-gaap Revenues
Revenues
261000
CY2019Q2 us-gaap Revenues
Revenues
4607000
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5417000
us-gaap Revenues
Revenues
8030000
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1404000
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9160000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
21074000
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3142000
CY2019Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
14179000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
14287000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
27013000
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3796000
us-gaap Revenues
Revenues
297000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
15893000
CY2020Q2 us-gaap Gross Profit
GrossProfit
-1143000
CY2019Q2 us-gaap Gross Profit
GrossProfit
-4553000
us-gaap Gross Profit
GrossProfit
-20777000
us-gaap Gross Profit
GrossProfit
-7863000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10134000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11933000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-12526000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-34653000
us-gaap Operating Income Loss
OperatingIncomeLoss
-56357000
us-gaap Operating Income Loss
OperatingIncomeLoss
-64421000
CY2020Q2 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
8000
CY2019Q2 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
410000
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
217000
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1037000
CY2020Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-6385000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-10931000
CY2020Q2 sens Interest Expense Excluding Debt Issuance Costs
InterestExpenseExcludingDebtIssuanceCosts
3555000
CY2019Q2 sens Interest Expense Excluding Debt Issuance Costs
InterestExpenseExcludingDebtIssuanceCosts
1965000
sens Interest Expense Excluding Debt Issuance Costs
InterestExpenseExcludingDebtIssuanceCosts
7928000
sens Interest Expense Excluding Debt Issuance Costs
InterestExpenseExcludingDebtIssuanceCosts
3999000
CY2020Q2 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
15238000
CY2019Q2 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
4889000
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
25549000
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
6961000
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-295000
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
245000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-658000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-17000
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5011000
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3579000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6249000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3982000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-7515000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
71261000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
94000
sens Adjustments To Additional Paid In Capital Share Based Compensation Stock Options And Restricted Stock Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAndRestrictedStockRequisiteServicePeriodRecognition
4257000
us-gaap Net Income Loss
NetIncomeLoss
-60439000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
15173000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-31074000
us-gaap Net Income Loss
NetIncomeLoss
-50108000
us-gaap Net Income Loss
NetIncomeLoss
-60439000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7515000
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-31074000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-50108000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-48961000
CY2020Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
14250000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1409000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.34
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
220305606
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
176983467
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
43944000
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
71000
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
177012497
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
212025792
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-60439000
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2019Q2 sens Adjustments To Additional Paid In Capital Share Based Compensation Stock Options And Restricted Stock Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAndRestrictedStockRequisiteServicePeriodRecognition
2232000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-31074000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
15173000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1212000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-7515000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-39605000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-8649000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-86000
sens Exercise Of Stock Options Vesting Of Rs Us And Espp Purchases
ExerciseOfStockOptionsVestingOfRSUsAndESPPPurchases
498000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
14250000
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
3278000
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1212000
us-gaap Net Income Loss
NetIncomeLoss
-50108000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-39605000
us-gaap Profit Loss
ProfitLoss
-50108000
us-gaap Profit Loss
ProfitLoss
-60439000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
569000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
418000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4650000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1830000
sens Gains Losses On Extinguishment Of Debt And Debt Modification Fees
GainsLossesOnExtinguishmentOfDebtAndDebtModificationFees
-10931000
sens Fair Value Adjustment Derivative Liability
FairValueAdjustmentDerivativeLiability
-25549000
sens Fair Value Adjustment Derivative Liability
FairValueAdjustmentDerivativeLiability
-6961000
us-gaap Share Based Compensation
ShareBasedCompensation
3278000
us-gaap Share Based Compensation
ShareBasedCompensation
4257000
us-gaap Inventory Write Down
InventoryWriteDown
11981000
us-gaap Inventory Write Down
InventoryWriteDown
2336000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-181000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-9709000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1295000
sens Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
1177000
sens Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
2106000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-798000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8892000
sens Increase Decrease In Deposit Assets And Other Assets
IncreaseDecreaseInDepositAssetsAndOtherAssets
15000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4179000
sens Proceeds From Exercise Of Stock Options And Espp Purchase
ProceedsFromExerciseOfStockOptionsAndESPPPurchase
94000
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
5763000
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
14437000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
48396000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
5000000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
372000
sens Increase Decrease In Accrued Liabilities And Other Current Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities
-6062000
sens Increase Decrease In Accrued Liabilities And Other Current Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities
2626000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-628000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-401000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
238000
sens Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-383000
sens Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-201000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-45777000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-65855000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
178000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
736000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-178000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-736000
sens Proceeds From Issuance Of Common Stock Net
ProceedsFromIssuanceOfCommonStockNet
-87000
sens Proceeds From Exercise Of Stock Options And Espp Purchase
ProceedsFromExerciseOfStockOptionsAndESPPPurchase
499000
sens Exchange Of Convertible Debt Net Amount
ExchangeOfConvertibleDebtNetAmount
-602000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-28386000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4906000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-74341000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-71497000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
95938000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
136793000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21597000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65296000
us-gaap Interest Paid Net
InterestPaidNet
3690000
us-gaap Interest Paid Net
InterestPaidNet
1858000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
20000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
170000
sens Proceeds From Issuance Of Common Stock And Warrants In Connection With Highbridge Transactions
ProceedsFromIssuanceOfCommonStockAndWarrantsInConnectionWithHighbridgeTransactions
8534000
us-gaap Notes Reduction
NotesReduction
24000000
us-gaap Notes Issued1
NotesIssued1
15675000
sens Number Of Geographical Markets
NumberOfGeographicalMarkets
2
CY2020Q2 sens Number Of Geographical Markets
NumberOfGeographicalMarkets
2
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenue and expenses during the reporting period. In the accompanying unaudited consolidated financial statements, estimates are used for, but not limited to, stock-based compensation, recoverability of long-lived assets, deferred taxes </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">and valuation allowances, derivative assets and liabilities, obsolete inventory, warranty obligations, variable consideration related to revenue, depreciable lives of property and equipment, and accruals for clinical study costs, which are accrued based on estimates of work performed under contract. The Company considered COVID-19 related impacts to its estimates, as appropriate, within its unaudited condensed consolidated financial statements and there may be changes to those estimates in future periods due to the uncertainties surrounding the severity and duration of the COVID-19 pandemic. Actual results could differ from those estimates; however, management does not believe that such differences would be material.</p>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2020Q2 us-gaap Cash
Cash
21394000
CY2019Q4 us-gaap Cash
Cash
38043000
CY2020Q2 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
3000
CY2019Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
37769000
CY2019Q4 us-gaap Commercial Paper At Carrying Value
CommercialPaperAtCarryingValue
13870000
CY2019Q4 us-gaap Asset Backed Securities At Carrying Value
AssetBackedSecuritiesAtCarryingValue
6256000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21397000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
95938000
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1011000
CY2019 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1915000
CY2020Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1589000
CY2019Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
2197000
sens Payment Period
PaymentPeriod
P60D
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21397000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
95938000
CY2020Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
200000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21597000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
95938000
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
200000
us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:14pt 0pt 0pt 0pt;"><span style="font-style:italic;font-weight:bold;">Warranty Obligation</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-indent:36pt;margin:14pt 0pt 0pt 0pt;"><span style="font-size:10pt;">The Company provides a warranty of </span><span style="font-size:10pt;">one year</span><span style="font-size:10pt;"> on its smart transmitters. Additionally, the Company may also replace Eversense system components that do not function in accordance with the product specifications. Estimated replacement costs are recorded at the time of shipment as a charge to cost of sales in the consolidated statement of operations and are developed by analyzing product performance data and historical replacement experience, including comparing actual return management authorizations to revenue.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt;">At June 30, 2020 and December 31, 2019, the warranty reserve was $1.6 million and $2.2 million, respectively. The following table provides a reconciliation of the change in estimated warranty liabilities as of June 30, 2020 and December 31, 2019 (in thousands):</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:2.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:2.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:middle;white-space:nowrap;width:65.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;margin-bottom:0pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:65.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-style:italic;margin-bottom:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:65.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">Balance at beginning of the year</p></td><td style="background-color:#cceeff;vertical-align:middle;white-space:nowrap;width:2.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 3.5pt 0.05pt 0pt;"> 2,197</p></td><td style="background-color:#cceeff;vertical-align:middle;white-space:nowrap;width:2.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 3.5pt 0.05pt 0pt;"> 816</p></td></tr><tr><td style="vertical-align:bottom;width:65.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">Provision for warranties during the period</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 3.5pt 0.05pt 0pt;"> 403</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 3.5pt 0.05pt 0pt;"> 3,296</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:65.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">Settlements made during the period</p></td><td style="background-color:#cceeff;vertical-align:middle;white-space:nowrap;width:2.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (1,011)</p></td><td style="background-color:#cceeff;vertical-align:middle;white-space:nowrap;width:2.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (1,915)</p></td></tr><tr><td style="vertical-align:bottom;width:65.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">Balance at end of the year</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 3.5pt 0.05pt 0pt;"> 1,589</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.07%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 3.5pt 0.05pt 0pt;"> 2,197</p></td></tr></table>
sens Product Warranty Term
ProductWarrantyTerm
P1Y
CY2020Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1600000
CY2019Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
2200000
CY2019Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
2197000
CY2018Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
816000
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
403000
CY2019 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
3296000
sens Patient Fee Basis To Determine Customer Reimbursement
PatientFeeBasisToDetermineCustomerReimbursement
99
sens Number Of Geographical Markets
NumberOfGeographicalMarkets
2
CY2019Q2 sens Number Of Geographical Markets
NumberOfGeographicalMarkets
2
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5688000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4512000
CY2019Q4 sens Prepaid Clinical And Preclinical Costs
PrepaidClinicalAndPreclinicalCosts
240000
CY2020Q2 sens Consulting
Consulting
125000
CY2020Q2 sens Prepaid Information Technology And Software Costs Current
PrepaidInformationTechnologyAndSoftwareCostsCurrent
107000
CY2019Q4 sens Prepaid Information Technology And Software Costs Current
PrepaidInformationTechnologyAndSoftwareCostsCurrent
294000
CY2020Q2 us-gaap Prepaid Rent
PrepaidRent
101000
CY2020Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
4000
CY2019Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
179000
CY2019Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
107000
CY2020Q2 sens Covid19 Relief Concessions Allowance
Covid19ReliefConcessionsAllowance
200000
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
125942324
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
53011287
CY2020Q2 sens Accrued Employee Termination Benefits
AccruedEmployeeTerminationBenefits
1400000
CY2020Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
278000
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3944000
CY2020Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1259000
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
10938000
CY2020Q2 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
2613000
CY2019Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
2047000
CY2020Q2 us-gaap Inventory Net
InventoryNet
4150000
CY2019Q4 us-gaap Inventory Net
InventoryNet
16929000
CY2020Q2 us-gaap Inventory Adjustments
InventoryAdjustments
15100000
CY2019Q2 us-gaap Inventory Adjustments
InventoryAdjustments
2200000
CY2020Q2 sens Prepaid Contract Manufacturing Current
PrepaidContractManufacturingCurrent
4158000
CY2019Q4 sens Prepaid Contract Manufacturing Current
PrepaidContractManufacturingCurrent
3043000
CY2020Q2 us-gaap Prepaid Insurance
PrepaidInsurance
678000
CY2019Q4 us-gaap Prepaid Insurance
PrepaidInsurance
44000
CY2020Q2 us-gaap Prepaid Advertising
PrepaidAdvertising
375000
CY2019Q4 us-gaap Prepaid Advertising
PrepaidAdvertising
605000
CY2020Q2 sens Prepaid Clinical And Preclinical Costs
PrepaidClinicalAndPreclinicalCosts
140000
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3007000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5630000
CY2020Q2 sens Accrued Contract Manufacturing Costs Current
AccruedContractManufacturingCostsCurrent
2685000
CY2019Q4 sens Accrued Contract Manufacturing Costs Current
AccruedContractManufacturingCostsCurrent
2452000
CY2020Q2 us-gaap Interest Payable Current
InterestPayableCurrent
1751000
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
2153000
CY2020Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1589000
CY2019Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
2197000
CY2020Q2 sens Accrued Patient Access And Incentive Programs Current
AccruedPatientAccessAndIncentiveProgramsCurrent
831000
CY2019Q4 sens Accrued Patient Access And Incentive Programs Current
AccruedPatientAccessAndIncentiveProgramsCurrent
1578000
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
744000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
696000
CY2020Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
705000
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1384000
CY2020Q2 sens Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
559000
CY2019Q4 sens Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
1956000
CY2020Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
255000
CY2019Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
553000
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
48000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
37000
CY2020Q2 sens Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
12174000
CY2019Q4 sens Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
18636000
CY2020Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
1635000
CY2020Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1863000
CY2020Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
57000
CY2020Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
3555000
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
3929000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3915000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
79000
us-gaap Interest Expense Debt
InterestExpenseDebt
7923000
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
22489000
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
12754000
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
15700000
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
58000000
CY2020Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
108943000
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
175289
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
100000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0

Files In Submission

Name View Source Status
R50.htm Edgar Link pending
0001558370-20-010163-index-headers.html Edgar Link pending
0001558370-20-010163-index.html Edgar Link pending
0001558370-20-010163.txt Edgar Link pending
0001558370-20-010163-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmb-20200630.xsd Edgar Link pending
tmb-20200630x10q.htm Edgar Link pending
tmb-20200630x10q_htm.xml Edgar Link completed
tmb-20200630xex31d1.htm Edgar Link pending
tmb-20200630xex31d2.htm Edgar Link pending
tmb-20200630xex32d1.htm Edgar Link pending
tmb-20200630_cal.xml Edgar Link unprocessable
tmb-20200630_def.xml Edgar Link unprocessable
tmb-20200630_lab.xml Edgar Link unprocessable
tmb-20200630_pre.xml Edgar Link unprocessable